logo
He needed his medication for multiple sclerosis. He got more paperwork instead.

He needed his medication for multiple sclerosis. He got more paperwork instead.

Boston Globe13-05-2025

In 2022, Blum's neurologist recommended he switch his primary MS medication to Kesimpta, which he takes by monthly self-injection. At the time, Blum was on medication that was administered by infusion twice a year in his doctor's office and fully covered by Medicare. Kesimpta, by contrast, would cost many thousands of dollars a year, way too expensive for Blum. (The switch was recommended mainly as a matter of convenience.)
That's when Blum discovered he was income-qualified for a no-cost supply of Kesimpta from the
Advertisement
NPAF said Blum would get his medication at no cost so long as there was no significant change in his finances, Blum said.
Advertisement
It was a godsend. For the next two and a half years, everything went smoothly. Blum would call NPAF to order his medication and it would arrive at his house in time for his monthly doses.
This is what Blum says happened next:
In January, when he tried to call in his order as usual, NPAF told him he had to reapply for enrollment. It annoyed him that he had received no advance warning of this new requirement, and it came only a couple of days before his next scheduled dose.
But he did as instructed by getting a note from his doctor, filling out a form, and returning both to NPAF, along with a copy of his 2023 tax return, all within 48 hours. (Patient assistance programs overall are tightening rules in response to scrutiny from regulators and the high cost of the programs.)
NPAF also required him to obtain documentation that he was not eligible for drug assistance from an alternative program — the Social Security Administration's
Nevertheless, he applied online for Extra Help to satisfy NPAF's requirements. The denial letter, however, would take up to 30 days to arrive in the mail, according to the SSA website.
Under these circumstances, NPAF provided Blum with his medication even without the denial letter, as a 'courtesy.'
A month later, when he tried to refill his medication, NPAF said it hadn't received the Extra Help denial letter. Blum said he was still waiting for it. NPAF agreed to a second 'courtesy' dose of his medication.
Advertisement
A short time later, the Extra Help letter finally came and Blum forwarded it to NPAF.
But in March, NPAF again denied Blum his medication. It said the Extra Help denial letter it received from Blum wasn't what it needed, though it didn't explain why.
Blum told NPAF that the SSA website contained a statement about eligibility that clearly excluded him. At NPAF's suggestion, he provided screenshots of the eligibility section of the online application for Extra Help.
That apparently was good enough for NPAF. Blum got his medication for March.
A month later, when Blum sought a refill, NPAF insisted on a formal denial letter, not screenshots. And this time, NPAF said it would not give him a courtesy refill, leaving Blum confused and demoralized.
In an email requesting my help, Blum said NPAF's rejection of the screenshots 'contradicted their previous directive' and came only days before he was supposed to take his next dose.
Blum said NPAF should have reached out to him as soon as it determined the screenshots were unacceptable, but instead it waited until he attempted to make a new order.
'Now they are refusing any further help,' he wrote to me.
The only way for Blum to receive his medication was to obtain an Extra Help denial letter. But he knew the process for applying, waiting for the letter, then forwarding it to NPAF would be time-consuming (if the letter was accepted at all), likely forcing him to miss at least one monthly dose and maybe more.
Advertisement
Blum also worried that recent staff cuts at Social Security could add new delays to getting his requested documentation.
Blum said he didn't expect an immediate deterioration in his health due to one or two missed doses, but it certainly wouldn't help.
The resolution
: I wrote to NPAF: 'It seems to me Mr. Blum has done everything in his power to comply with NPAF's requirements, but the requirements' seem to have constantly changed.
'Mr. Blum needs his medication,' I wrote.
NPAF reacted quickly by promptly delivering Blum his medication and assuring him he would continue to get it at least until it's time to reapply for enrollment next year. Blum said he was relieved and grateful, though he's a bit wary of what might unfold next year.
The takeaway
: NPAF, in a statement to me, declined to comment specifically on Blum. But it did say that NPAF patients were informed of the new enrollment process and requirements in 'multiple letters sent out in October-December 2024.'
Blum said he received no such letters. Could he have missed them in the mail? 'Highly unlikely,' he said. 'I'm extremely attentive to anything having to do with my health and medication.'
In any case, the requirements kept changing. And life is tough enough without these added headaches. What can a consumer learn from Blum's unfortunate experience? Beware that something can always go wrong when it comes to medications and paperwork. Even when things are going smoothly, ask questions and seek assurances, preferably in writing. Anticipate problems, be proactive, document everything — and be persistent.
Got a problem? Send your consumer issue to

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NCOA Applauds Reintroduction of Treat and Reduce Obesity Act
NCOA Applauds Reintroduction of Treat and Reduce Obesity Act

Yahoo

timean hour ago

  • Yahoo

NCOA Applauds Reintroduction of Treat and Reduce Obesity Act

Bipartisan legislation would expand Medicare coverage of comprehensive obesity treatments View in browser Key Takeaways: The Treat and Reduce Obesity Act (TROA) has been reintroduced in the U.S. Senate. Reintroduction in the U.S. House of Representatives is expected soon. If passed and signed into law, TROA would require Medicare to cover anti-obesity medications, including GLP-1s, and expand access to intensive behavioral therapy for weight management. TROA has historically gained bipartisan support and was first introduced in Congress over 10 years ago. ARLINGTON, Va., June 5, 2025 /PRNewswire/ -- The National Council on Aging (NCOA), the national voice for every person's right to age well, applauds today's reintroduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the U.S. Senate. Led by Sens. Bill Cassidy, R-La., and Ben Ray Luján, D-N.M., TROA would expand Medicare coverage for the full continuum of obesity care, recognizing obesity as a chronic, treatable disease that affects 40 percent of older Americans. First introduced in 2013, TROA aims to improve Medicare by removing outdated barriers to quality obesity care. The legislation has consistently received bipartisan support, highlighting a growing agreement among policymakers about the need to tackle the nation's obesity epidemic. "Obesity is a chronic condition that has affected millions of Americans for decades, but getting adequate care remains stubbornly difficult for too many older adults," said Ramsey Alwin, NCOA President and CEO. "The reintroduction of TROA is a welcome and vital step toward ensuring all Americans have access to the full range of obesity treatments." The legislation would repeal an outdated statute that prevents Medicare Part D from covering FDA-approved obesity medications. TROA also enhances access to intensive behavioral therapy (IBT) under Medicare Part B, which under current policy can only be provided by primary care doctors. TROA expands access to IBT to ensure a broader array of health care providers, including registered dietitian nutritionists, obesity medicine specialists, endocrinologists, bariatric surgeons, clinical psychologists, and community-based providers. By expanding access to lifestyle-based interventions like IBT, TROA ensures patients with obesity will have access to the full spectrum of obesity care. Obesity is linked to over 200 medical conditions and is responsible for an estimated 400,000 deaths annually. In addition to the health impacts of obesity, it is also an expensive disease, costing an estimated $173 billion in the United States in 2019. Expanding insurance coverage of obesity treatments could help reduce the cost burden of obesity to both patients and all Americans. According to the USC Schaffer Center, access to innovative anti-obesity medicines, including GLP-1s, can produce a 13% return on investment. Another recent study found that employees taking anti-obesity medications saw reduced growth in medical cost rates over two years compared to those not taking them, resulting in lower costs for their employers in addition to significant health improvements. NCOA has advocated for older adults with obesity to be treated fairly by providers free from weight stigma and bias. With the National Consumers League, NCOA helped develop the Obesity Bill of Rights in 2024. About NCOAThe National Council on Aging (NCOA) is the national voice for every person's right to age well. Working with thousands of national and local partners, we provide resources, tools, best practices, and advocacy to ensure every person can age with health and financial security. Founded in 1950, we are the oldest national organization focused on older adults. Learn more at and @NCOAging. View original content to download multimedia: SOURCE National Council on Aging Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Medicare Emerges as Target for Cuts to Offset Trump Tax Bill
Medicare Emerges as Target for Cuts to Offset Trump Tax Bill

Bloomberg

timean hour ago

  • Bloomberg

Medicare Emerges as Target for Cuts to Offset Trump Tax Bill

By , Steven T. Dennis, and Erik Wasson Updated on Save Senate Republicans are considering cuts to Medicare spending to help pay for Donald Trump's signature legislative package. The GOP lawmakers are proceeding cautiously as they expand their search for savings to a popular health insurance program nearly all Americans rely upon in retirement, presenting the move as an effort to root out waste, fraud and abuse. That includes cutting payments to health insurance companies that run private Medicare plans.

Senate GOP eyes Medicare cuts with Trump's blessing
Senate GOP eyes Medicare cuts with Trump's blessing

Axios

timean hour ago

  • Axios

Senate GOP eyes Medicare cuts with Trump's blessing

President Trump gave Republican senators a green light to explore ways to save money on Medicare during a meeting at the White House, senators said Thursday. Why it matters: Changes to save money on Medicaid have already proven contentious with some Republicans. Medicare could open a new can of worms. "The president is willing to eliminate any waste, fraud and abuse anywhere," Sen. Ron Johnson (R-Wisc.) told Axios about the White House meeting Wednesday night that he attended, "which opens up Medicare, as well," he added. "What the president made clear is he does not want to see any cuts to beneficiaries, but to go after... the waste, fraud and abuse," said Sen. Steve Daines (R-Mont.), clarifying that Trump opened up Medicare as an option at the meeting. Politico first reported on the Medicare discussions. What to watch: One possibility being floated is a bill from Sen. Bill Cassidy (R-La.), which would get savings from the Medicare Advantage program. The measure would crack down on an insurer practice known as "upcoding," where health insurers classify patients as sicker in order to secure higher government payments. Cracking down on the practice has some support from Democrats as well, but would be sure to draw the opposition of the health insurance industry.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store